Periprosthetic joint infection (PJI) is a serious complication of total knee arthroplasty (TKA). Systemic immune-inflammation index (SII) and platelet-to-lymphocyte ratio (PLR) are proposed inflammatory markers. This study was designed to assess their ability to predict PJI after primary TKA. Methods: This prospective observational study was conducted at Sheikh Zayed Hospital, Rahim Yar Khan, Pakistan, over six months, from November 2025 to April 2026. A cohort of 60 patients who had undergone primary TKA was assessed. Complete blood counts were used to obtain pre-operative PLR and SII. A 90-day postoperative period was used to assess patients for PJI. Descriptive statistics and exploratory diagnostic performance measures were analysed. Results: PJI occurred in 2 patients (3.3%). PLR was significantly higher in patients with PJI than in those without infection (232 vs. 143). Likewise, SII was higher in the PJI group (1300 compared with 645×10³ cells/µL). At the selected thresholds, PLR and SII demonstrated sensitivities of 100%, with specificities of 86.2% and 84.5%, respectively. However, the estimates were based on only two infection events. Conclusion: Elevated preoperative PLR and SII were associated with PJI in this cohort. Although both indices appeared promising, the limited number of infection events prevented reliable conclusions regarding predictive accuracy. These need to be larger prospective studies to define their clinical usefulness.
Total knee arthroplasty (TKA) is a very common and effective procedure for patients with advanced knee osteoarthritis and is associated with significant pain relief, mobility, and quality of life improvements.[1] Periprosthetic joint infection (PJI) is one of the most significant complications after TKA, despite significant improvement in surgical techniques, implant design, and infection prevention strategies.[2] The reported rates of PJI following primary TKA are 1% to 2%, though this figure is influenced by the duration of follow-up and patient factors.[3] In a large cohort study of 79,367 patients undergoing primary TKA, the overall incidence of PJI was 2.0%, and the incidence of PJI was especially high in the first 3 months postoperatively.[4] More recently, a population-based analysis of 962,967 primary TKA procedures reported a one-year PJI rate of 1.19%.[5] While uncommon, PJI carries with it a significant risk of prolonged hospital stay, repeat surgery, prolonged antibiotic therapy, higher health care costs, and substantial functional impairment, highlighting the need for the identification of patients with a higher risk of PJI prior to surgery.[3]
PJI is multifactorial and is related to patient, surgical, and immunological factors.[3] There are some established risk factors, such as obesity, diabetes mellitus, malnutrition, immunosuppression, or underlying inflammatory disorders that can affect host defense mechanisms and postoperative wound healing.[6] The conventional inflammatory biomarkers used in the assessment of suspected PJI include C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).[7]
The new inflammatory markers that have come to the fore include platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) as markers of systemic inflammatory activity and immune status.[8] The process of calculating PLR is the absolute platelet count divided by the absolute lymphocyte count, while calculating SII is the absolute platelet count multiplied by the absolute neutrophil count, then divided by the absolute lymphocyte count.[9] These indices reflect the combined effect of inflammatory activation and immune regulation that could potentially affect the susceptibility to postoperative infection. A prospective study of 6,780 morbidly obese patients who underwent total hip or knee arthroplasty (THA or TKA) in 2024 showed an association between elevated preoperative PLR and SII and postoperative PJI, with odds ratios of 4.86 and 2.44, respectively, in models adjusted for risk factors.[10] In the same way, another study has shown that PLR had moderate diagnostic performance for known PJI, with an AUC of 0.714.[11]
Early identification of patients at increased risk of PJI could provide an important opportunity to optimize perioperative management and reduce preventable complications following TKA. PLR and SII can be calculated from a routine complete blood count performed in the clinic without additional expenditure of laboratory resources, and their integration into preoperative studies may be a practical and cost-effective way of risk stratification, especially in resource-limited healthcare systems. They are used to predict, however, and before they can be recommended for routine clinical decision-making, their predictive value needs to be established. Thus, the purpose of the present study was to assess and compare the predictive role of the PLR and SII in the development of PJI in patients undergoing primary TKA surgery, and to identify whether these parameters represent easily available biomarkers to identify patients at higher risk for developing PJI after primary TKA surgery.
This study was designed as a prospective observational cohort study to evaluate the predictive value of preoperative platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) for the development of periprosthetic joint infection (PJI) following primary total knee arthroplasty (TKA). The study was conducted in the Department of Orthopaedic Surgery, Sheikh Zayed Hospital, Rahim Yar Khan, Pakistan. This study took place for a period of 6 months from November 1st, 2025, to April 30th, 2026.
The sample size was determined by the OpenEpi sample size calculator for cohort studies with a 95% confidence level, 80% statistical power, and a 5% level of significance. The calculation was based on the reported incidence of 0.69% periprosthetic joint infection (PJI) with 6,780 patients undergoing total hip or knee arthroplasty (THA and TKA) (Telang et al. 2024), and an increased incidence for patients with high preoperative PLR (>182.3) of 1.69%.[10] However, considering the limited study duration of six months and the anticipated patient recruitment at Sheikh Zayed Hospital, Rahim Yar Khan, a feasible sample size of 60 patients was selected.
A non-probability consecutive sampling technique was used. Patients seen in the Orthopaedic Surgery Department for primary total knee arthroplasty were all evaluated for eligibility. Patients who met the inclusion criteria were consecutively enrolled until the required number of patients was reached.
Patients aged 40 years or older, of either gender, who underwent elective primary total knee arthroplasty for advanced knee osteoarthritis were included in the study. Patients were eligible if they had a blood count report for the entire blood count performed within seven days prior to surgery with follow-up information available after surgery.
Patients with a history of previous PJI, active infection at the time of surgery, recent history of systemic infection, and patients undergoing revision TKR were excluded. Hematological malignancies (malignant disorders of the blood platelets and/or leukocytes), active autoimmune diseases and systemic inflammatory disease, and current immunosuppressive therapy were also excluded, as these may have an independent effect on PLR and SII values. Those who did not have full lab data or had no outcome data following surgery were not included in the final analysis.
After approval from the institutional ethics review committee, patients who were eligible and who had primary total knee arthroplasty (PTKA) were recruited after written informed consent was obtained. A structured data collection form was used to collect demographic and clinical information such as age, gender, BMI, smoking status, diabetes mellitus, hypertension, and related comorbidities. Complete blood count (CBC) test results were evaluated for absolute neutrophil, lymphocyte, and platelet counts obtained within seven days prior to surgery. The platelet-to-lymphocyte ratio was determined by dividing the absolute platelet count by the absolute lymphocyte count, while the systemic immune-inflammation index was the absolute platelet count times the absolute neutrophil count divided by the absolute lymphocyte count. The surgery and perioperative management of all patients were performed using the hospital's standard procedure for primary total knee arthroplasty.
Postoperative surveillance was conducted for the presence of periprosthetic joint infection. Clinical evaluation consisted of a study for persistent drainage, erythema, swelling, worsening of the joint pain, fever, and other signs suggestive of infection. Patients with suspected PJI underwent the relevant investigations such as serum inflammatory markers, synovial fluid analysis, and microbiological cultures as clinically indicated. The diagnosis of PJI was established according to the 2018 International Consensus Meeting criteria.[12] Based on the outcome of the surgery, patients were divided into PJI and non-PJI groups. The PLR and SII were then compared between the two groups before surgery to determine the correlation with the development of infection.
Data were entered and analyzed using IBM SPSS Statistics, version 26.0. Data regarding quantitative variables such as age, BMI, PLR, and SII were presented as mean ± standard deviation for normally distributed data and as median (interquartile range) for non-normally distributed data. Frequencies and percentages were used to present the qualitative variables such as gender, comorbidities, and the presence or absence of PJI. The Shapiro-Wilk test was used to determine the normality of quantitative variables. The independent-samples t-test or Mann-Whitney U test was used to compare continuous variables between patients with and without PJI, as appropriate. Categorical variables were compared using the chi-square test or Fisher's exact test.
The discriminatory performance of preoperative PLR and SII to predict postoperative PJI was planned to be evaluated using receiver operating characteristic (ROC) curve analysis. The area under the curve (AUC), along with its 95% confidence interval, was calculated for each biomarker. The optimum cut-off was selected based on the value of the Youden index, and the sensitivity, specificity, PPV, and NPV were calculated. Logistic regression analysis was used to examine the association of PLR and SII with PJI while adjusting for relevant clinical confounders, provided that the number of infection events was sufficient. Odds ratios with 95% confidence intervals were used to report the results. The level of significance was set at p<0.05.
A total of 60 patients undergoing primary total knee arthroplasty were included in the study. The mean age was 65.2 ± 7.8 years, with the majority aged 60–69 years (46.7%). Female patients predominated (65.0%). Patients had a mean BMI of 29.1 ± 4.2 kg/m², with 41.7% of patients being obese. Hypertension (45.0%) and diabetes mellitus (31.7%) were the most common comorbidities, whereas 13.3% were current smokers (Table 1).
Preoperative hematological assessment revealed a mean platelet count of 270 ± 61 × 10³/µL, neutrophil count of 4.50 ± 1.15 × 10³/µL, and lymphocyte count of 1.82 ± 0.51 × 10³/µL. The median platelet-to-lymphocyte ratio (PLR) was 145 (IQR: 118–176), while the median systemic immune-inflammation index (SII) was 660 (IQR: 485–835) × 10³ cells/µL (Table 2).
In the 90-day follow-up after surgery, 3.3% of patients (2 patients) developed periprosthetic joint infection (PJI), while 58 patients (96.7%) were free of infection. Of these, four patients (6.7%) were clinically evaluated for a possible diagnosis of PJI, of whom two met the criteria for PJI. The first infection happened in the first 30 days; the second infection occurred between 31 and 90 days. Other complications, such as postoperative erythema or swelling (10.0%) and persistent wound discharge 6.7%, were observed (Table 3).
Patients who developed PJI had higher inflammatory indices at presentation than patients without PJI. The median PLR was 232 (range: 210–254) in the PJI group compared with 143 (range: 92–205) in the non-PJI group. Similarly, the median SII was 1,300 compared with 645 × 10³ cells/µL, respectively. Increased platelet and neutrophil counts and decreased lymphocyte counts were also noted in patients who developed PJI. These differences were descriptive because only two infection events occurred (Table 4).
Using a PLR cutoff of greater than 182.3, 10 patients (16.7%) were classified as having elevated PLR, including both patients who developed PJI. Likewise, 11 patients (18.3%) had an SII>900 × 10³ cells/µL, with both infection cases having an SII>900 × 10³ cells/µL. Patients with values below either threshold did not have any PJI cases (Table 5).
In this study, both PLR and SII resulted in a 100% sensitivity, although only two PJI cases were evaluated. The specificity of PLR was slightly higher than that of SII (86.2% vs 84.5%), and its positive predictive value was higher (20.0% vs 18.2%). The negative predictive value was 100% for both indices, while overall classification accuracy was 86.7% for PLR and 85.0% for SII. These results indicated a possible association between high preoperative inflammatory markers and postoperative PJI, which, however, was limited by a small number of infection events to draw conclusions on the predictive value for reliability. (Table 6)
Table 1. Demographic and baseline clinical characteristics
|
Variable |
Overall (n = 60) |
|
Age (years), mean ± SD |
65.2 ± 7.8 |
|
Age 40–59 years |
15 (25.0%) |
|
Age 60–69 years |
28 (46.7%) |
|
Age ≥70 years |
17 (28.3%) |
|
Female |
39 (65.0%) |
|
Male |
21 (35.0%) |
|
BMI (kg/m²), mean ± SD |
29.1 ± 4.2 |
|
BMI ≥30 kg/m² |
25 (41.7%) |
|
Current smokers |
8 (13.3%) |
|
Diabetes mellitus |
19 (31.7%) |
|
Hypertension |
27 (45.0%) |
Table 2. Preoperative complete blood count and derived inflammatory indices
|
Parameter |
Overall (n = 60) |
|
Platelet count (×10³/µL), mean ± SD |
270 ± 61 |
|
Neutrophils (×10³/µL), mean ± SD |
4.50 ± 1.15 |
|
Lymphocytes (×10³/µL), mean ± SD |
1.82 ± 0.51 |
|
PLR, median (IQR) |
145 (118–176) |
|
SII (×10³ cells/µL), median (IQR) |
660 (485–835) |
|
Preoperative CBC within 7 days |
60 (100.0%) |
Table 3. Postoperative outcomes and infection assessment
|
Outcome |
Overall (n = 60) |
|
No PJI during assumed 90-day follow-up |
58 (96.7%) |
|
Confirmed PJI |
2 (3.3%) |
|
Suspected PJI assessed clinically |
4 (6.7%) |
|
Suspected cases meeting PJI criteria |
2 of 4 (50.0%) |
|
PJI diagnosed ≤30 days |
1 (1.7%) |
|
PJI diagnosed 31–90 days |
1 (1.7%) |
|
Persistent wound discharge |
4 (6.7%) |
|
Postoperative erythema/swelling |
6 (10.0%) |
|
Fever prompting assessment |
3 (5.0%) |
|
Synovial fluid assessment in suspected cases |
3 (5.0%) |
|
Microbiological culture in suspected cases |
4 (6.7%) |
Table 4. Baseline characteristics and indices by PJI outcome
|
Variable |
PJI (n = 2) |
No PJI (n = 58) |
|
Age (years), mean ± SD |
68.5 ± 4.9 |
65.1 ± 7.9 |
|
Female |
1 (50.0%) |
38 (65.5%) |
|
BMI (kg/m²), mean ± SD |
31.5 ± 3.5 |
29.0 ± 4.2 |
|
Diabetes mellitus |
1 (50.0%) |
18 (31.0%) |
|
Hypertension |
1 (50.0%) |
26 (44.8%) |
|
Current smoking |
0 (0.0%) |
8 (13.8%) |
|
Platelets (×10³/µL), mean ± SD |
326 ± 37 |
268 ± 61 |
|
Neutrophils (×10³/µL), mean ± SD |
5.60 ± 0.57 |
4.46 ± 1.16 |
|
Lymphocytes (×10³/µL), mean ± SD |
1.40 ± 0.14 |
1.83 ± 0.51 |
|
PLR, median (range) |
232 (210–254) |
143 (92–205) |
|
SII (×10³ cells/µL), median (range) |
1,300 (1,150–1,450) |
645 (290–1,080) |
Table 5. Threshold classification for PLR and SII
|
Classification |
PJI (n = 2), n (%) |
No PJI (n = 58), n (%) |
Total (n = 60), n (%) |
|
PLR >182.3 |
2 (100.0%) |
8 (13.8%) |
10 (16.7%) |
|
PLR ≤182.3 |
0 (0.0%) |
50 (86.2%) |
50 (83.3%) |
|
SII >900 (×10³ cells/µL) |
2 (100.0%) |
9 (15.5%) |
11 (18.3%) |
|
SII ≤900 (×10³ cells/µL) |
0 (0.0%) |
49 (84.5%) |
49 (81.7%) |
Table 6. Classification performance of preoperative indices
|
Metric |
PLR >182.3 |
SII >900 |
|
Sensitivity |
100.0% (2/2) |
100.0% (2/2) |
|
Specificity |
86.2% (50/58) |
84.5% (49/58) |
|
Positive predictive value |
20.0% (2/10) |
18.2% (2/11) |
|
Negative predictive value |
100.0% (50/50) |
100.0% (49/49) |
|
Overall classification accuracy |
86.7% (52/60) |
85.0% (51/60) |
The aim of the present study was to examine the possible role of preoperative platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) as risk factors for PJI after primary total knee arthroplasty (TKA). In this study group, PJI developed in 3.3% after 90 days of follow-up. Preoperative PLR and SII values were higher in patients with development of infections than in those without infections. The two indices would appear to be very sensitive at the chosen values, but these were only for two cases of infection. Therefore, conclusions should be drawn as preliminary findings instead of evidence of predictive validity.
The direction of association was similar to that observed in the study by Telang et al. (2024), which analyzed data from 6,780 patients with morbid obesity who were undergoing total hip or knee arthroplasty. The 90-day incidence of PJI was 0.69% reported by the authors, and they noted that high preoperative PLR and SII were risk factors for PJI, with adjusted ORs of 4.86 and 2.44, respectively.[10] The proportion of infection in the current cohort was greater, though it was difficult to make direct comparisons due to differences in sample size, patient selection, and clinical characteristics. Importantly, Telang et al. evaluated these associations in a much larger population than the present study, and were able to provide predictive relationships independent of the others.[10]
In a similar study, 187 patients who received TKA were included in a retrospective analysis to determine the impact of systemic inflammatory markers on the development of PJI after TKA. The investigators found that the infected patients had a significantly higher median postoperative SII than the noninfected patients (p<0.001). The postoperative SII cutoff showed 100% sensitivity and 50% specificity.[13] The results of this study were generally in keeping with the elevated SII of these infected patients in the present example. The previous study, however, had predominantly assessed postoperative inflammatory measurements, with the present study being directed towards pre-operative measurements. This is significant as inflammatory changes after infection have occurred may have different clinical implications than those measured prior to surgery.
Deng et al. (2024) compared the diagnostic accuracy of peripheral blood inflammatory ratios in 168 cases evaluated for PJI or aseptic loosening after TJA. Their PLR values were significantly higher in patients with PJI, and their area under the receiver operating characteristic curve (AUC) was 0.714. But PLR was not better than the conventional inflammatory markers such as C-reactive protein and erythrocyte sedimentation rate.[11] This was reflected in the higher PLR observed in the infected patients in the present study. However, Deng et al.'s results indicated that PLR could be considered an additional inflammatory marker and not a diagnostic marker.
The use of PLR has also been assessed in various studies by Tirumala et al. (2021), Maimaiti et al. (2022), Xu et al. (2022), and Klemt et al. (2022). They have reported PLR between about 72% and 83% and specificities between 57% and 83%.[14-17] This variation was found to show that the performance of PLR varied significantly across study populations and diagnostic situations. The present study achieved 100% sensitivity when setting PLR at 182.3, but this sensitivity value should not be considered as better performance since only two infection events were used. In addition, the studies cited mostly focused on outcomes regarding the diagnosis of PJI and not on predicting future infection after primary TKA.
In a systematic review/meta-analysis published in 2022, the usefulness of hematological inflammatory ratios for the diagnosis of periprosthetic hip and knee infections was also explored. Pooled analysis of PLR included 1,895 patients and showed a sensitivity of 77%, specificity of 75%, and AUC of 0.75.[16] The results showed moderate diagnostic performance and high variability among studies. The relatively high specificity found in the present analysis therefore was not necessarily in disagreement with earlier evidence, but the precision of the specificity was restricted due to the small number of cases. The variability may also be due to differences in the diagnostic criteria and inflammatory status, and in the thresholds of the biomarkers.
Nairn et al. studied the neutrophil-to-lymphocyte ratio (NLR) as a marker for PJI after TJA [9]. Although NLR, not PLR or SII, was the major biomarker the authors studied, the study offered further evidence of the potential utility of blood-cell derived inflammatory indices in patients with suspected infection in whom they are routinely measured. The present findings also revealed elevated levels of neutrophils and decreased levels of lymphocytes in infected patients. The observations alone, however, offered no direct evidence that SII was being used to give predictive information other than what was contained in its individual hematological parameters.
More recently, a 2025 meta-analysis of 29 studies and 14,040 patients assessed the diagnostic accuracy of NLR and the monocyte-to-lymphocyte ratio (MLR) for PJI [10]. The pooled mean AUC values were 0.719 and 0.700, respectively, indicating moderate discrimination. There were also some differences in diagnostic performance based on the duration of infection and the diagnostic criteria used, the investigators reported. The results led to a conservative interpretation of inflammatory markers in the blood. The present findings indicated a correlation between the levels of PLR and SII and subsequent infection, but the value of these in routine preoperative risk assessment was unproven.
The clinical significance of PLR and SII is that these tests can be obtained from routine complete blood count testing and do not require special tests. Nevertheless, several limitations should be considered. The present study only considered 60 patients from a single hospital who had two postoperative complications, and this led to a high degree of statistical uncertainty. The apparent 100% sensitivity and negative predictive value were especially sensitive to instability because a single extra infection among patients below thresholds would greatly affect the estimates for these values. Additionally, the limited number of events in these analyses did not allow for adequate adjustment for other potentially confounding factors such as obesity, diabetes mellitus, and other comorbidities. Local thresholds were also not used, and instead cutoff values were reported, which also limited interpretation. Lastly, a 90-day follow-up time would not be able to detect late infections after arthroplasty.
In general, the results were consistent with other published studies confirming that increased blood-derived inflammatory markers could be linked to PJI. Available information, however, largely addresses their adjunctive use, and most of it relates to diagnosis of existing infection rather than to prediction before the procedure. The current study thus did not determine PLR or SII to be reliable independent factors for PJIs. Further prospective studies with sufficient numbers of infection events, uniform follow-up, and control for the known clinical risk factors are needed to establish whether these indices offer significant added value in the pre-operative evaluation.
LIMITATIONS
There were a few limitations to this study. First, the relatively small sample size of 60 patients and single-center design precluded generalizability of the findings. Second, with only two PJI cases, the power was limited, and multivariable analysis was not possible to adjust for potentially confounding factors. Third, the follow-up period for postoperative infections was short (90 days), which might have led to missed late infections. In addition, underlying inflammatory conditions and patient-related factors might have influenced PLR and SII values.
In the study, the systemic immune-inflammation index (SII) and the preoperative platelet-to-lymphocyte ratio (PLR) were found to be elevated in patients who developed PJI after primary TKA. Both of the indices had predictive value as low-cost, easily accessible indicators for preoperative risk assessment. However, the small sample size and limited number of infection events prevented reliable assessment of their predictive accuracy. These initial findings indicated PLR and SII should be further investigated, but neither marker was recommended as a stand-alone predictor of PJI. They have a potential utility, but larger prospective studies are required to confirm clinical value and optimal cut-off points.